Mutations in the EGFR gene can lead to uncontrolled cell division and tumor growth. These mutations are often found in various types of cancer, most notably non-small cell lung cancer (NSCLC), but also in others like glioblastomas and colorectal cancers. The mutations cause the EGFR protein to be constantly active, even in the absence of its ligand, leading to increased cell proliferation and survival.
